Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BostonSight, formerly known as the Boston Foundation for Sight, is a nonprofit healthcare organization and medical device company specializing in the treatment of diseased or damaged corneas. The company is best known for developing PROSE (Prosthetic Replacement of the Ocular Surface Ecosystem) therapy and the BostonSight Scleral lens, which are designed to restore vision and support ocular surface healing. Their technology utilizes custom-designed, gas-permeable scleral lenses that create a fluid-filled reservoir over the cornea to treat severe ocular surface disease and irregular corneal geometry. BostonSight operates a specialized clinic and a state-of-the-art manufacturing lab to produce highly customized prosthetic devices for patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston Foundation.